Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

A woman from Ellsworth is navigating life with a rare neuromuscular disease. Tina Bruning learned of her diagnosis of Generalized Myasthenia Gravis or gMG in May of 2021.

Abby Smith, 40, a NHS manager from Reading, has the rare autoimmune disease myasthenia gravis, which means she needs her ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

Recent studies have linked myasthenia gravis-related antibodies to PSF, though data on their role remains limited. Current treatments for PSF are often ineffective, underscoring the need for more ...

Post-treatment, all patients exhibited satisfactory improvements. The Myasthenia Gravis Foundation of America Quantitative Myasthenia Gravis (MGFA-QMG) scores, 15-item Myasthenia Gravis Quality of ...

So with FcRn blockade, you therefore have the ability to selectively target one of the underlying causes of myasthenia gravis: by reducing from circulation these autoantibodies. And you'll hear us ...

Myasthenia gravis is a chronic autoimmune disorder that causes muscle weakness and fatigue, often requiring chronic immunosuppressive medicines. Descartes-08 is designed to target B-cell maturation ...

Mestinon (pyridostigmine) is a prescription drug used to treat myasthenia gravis. This drug can interact ... An interaction can occur because one substance causes another substance to have a ...

Myasthenia gravis (MG) is a chronic autoimmune disorder that causes disabling muscle weakness and fatigue. For most people with MG, the disease is characterized by the presence of antibodies against ...

Myasthenia gravis (MG) is a chronic autoimmune disorder that causes disabling muscle weakness and fatigue. For most people with MG, the disease is characterized by the presence of antibodies ...